Driving drug development, differently
Elixion develops novel therapeutics through a dual: proprietary in-house programmes and selected co-development partnerships. Our unique R&D approach covers the full discovery process – from target identification to pre-clinical – focusing on complex diseases where precision, speed, and insight matter most.
Internal pipeline development
Advancing in-house programmes in carefully selected therapeutic areas with clear unmet patient need and strategic fit.
Strategic co-development
Collaborating with leading biopharma and research institutions to share knowledge and solve complex biological problems.